TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+5.92%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$483M
AUM Growth
+$483M
(+16%)
Cap. Flow
+$40.1M
Cap. Flow
% of AUM
8.3%
Top 10 Holdings %
Top 10 Hldgs %
61.19%
Holding
32
New
12
Increased
7
Reduced
8
Closed
4
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$39M |
| 2 |
Bristol-Myers Squibb
BMY
|
$20.1M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$19.9M |
| 4 |
Idexx Laboratories
IDXX
|
$18.6M |
| 5 |
UnitedHealth
UNH
|
$14.2M |
Top Sells
| 1 |
Pfizer
PFE
|
$50.2M |
| 2 |
Vaxcyte
PCVX
|
$31.1M |
| 3 |
United Therapeutics
UTHR
|
$19.7M |
| 4 |
Natera
NTRA
|
$18.2M |
| 5 |
Stevanato
STVN
|
$16.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $53.4M | 11.06% | 2,423,116 -332,621 | -12% | -$7.33M |
|
|
2
Zimmer Biomet
ZBH
$21B
| $39M | 8.07% | +369,004 | New | +$39M |
|
3
argenx
ARGX
$43.6B
| $35.8M | 7.42% | 58,258 -4,216 | -7% | -$2.59M |
|
|
4
Natera
NTRA
$23.1B
| $32.1M | 6.65% | 202,646 -114,793 | -36% | -$18.2M |
|
5
Inspire Medical Systems
INSP
$2.77B
| $28M | 5.79% | 150,788 -641 | -0.4% | -$119K |
|
|
6
Stevanato
STVN
$6.28B
| $24.4M | 5.06% | 1,121,804 -746,134 | -40% | -$16.3M |
|
7
Axsome Therapeutics
AXSM
$6.05B
| $21.1M | 4.38% | 249,769 +158,048 | +172% | +$13.4M |
|
|
VRNA
8
Verona Pharma
VRNA
$9.16B
| $21.1M | 4.37% | 454,201 -139,779 | -24% | -$6.49M |
|
|
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.43B
| $20.4M | 4.22% | 1,937,984 +277,029 | +17% | +$2.91M |
|
|
10
Bristol-Myers Squibb
BMY
$96B
| $20.1M | 4.16% | +355,366 | New | +$20.1M |
|
|
11
Jazz Pharmaceuticals
JAZZ
$7.75B
| $19.9M | 4.13% | +161,812 | New | +$19.9M |
|
|
12
Idexx Laboratories
IDXX
$51.8B
| $18.6M | 3.85% | +44,972 | New | +$18.6M |
|
13
Novo Nordisk
NVO
$251B
| $18.1M | 3.74% | 209,984 +142,727 | +212% | +$12.3M |
|
14
Madrigal Pharmaceuticals
MDGL
$9.76B
| $14.6M | 3.03% | 47,472 +4,185 | +10% | +$1.29M |
|
15
Merus
MRUS
$4.98B
| $14.6M | 3.03% | 347,303 +155,146 | +81% | +$6.52M |
|
|
16
UnitedHealth
UNH
$281B
| $14.2M | 2.95% | +28,115 | New | +$14.2M |
|
17
Janux Therapeutics
JANX
$1.37B
| $12.7M | 2.62% | +236,407 | New | +$12.7M |
|
18
Legend Biotech
LEGN
$6.41B
| $12.6M | 2.62% | 388,704 +26,434 | +7% | +$860K |
|
19
Cigna
CI
$80.3B
| $11.3M | 2.33% | +40,810 | New | +$11.3M |
|
20
GeneDx Holdings
WGS
$3.72B
| $9.8M | 2.03% | +127,567 | New | +$9.8M |
|
21
Geron
GERN
$893M
| $8.75M | 1.81% | +2,472,836 | New | +$8.75M |
|
22
Evolus
EOLS
$494M
| $8.2M | 1.7% | +742,574 | New | +$8.2M |
|
23
MindMed
MNMD
$676M
| $5.71M | 1.18% | 820,793 -842,160 | -51% | -$5.86M |
|
24
Korro Bio
KRRO
$217M
| $5.49M | 1.14% | 144,216 +80,202 | +125% | +$3.05M |
|
25
Biohaven
BHVN
$1.63B
| $5.24M | 1.08% | 140,220 -52,975 | -27% | -$1.98M |
|